explore -WSS

explore

author：comprehensive 2025-09-29 01:38:30 - browse：69

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

WSS

A letter from the executive editor: STAT UnitedHealth investigation

Study suggests Covid rebound is far more common with Paxlovid than without

White House drug czar issues call for 'recovery

Congress must give Medicare recipients genetic counseling access

Cancer drug shortages' outsize impact on ovarian cancer patients

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

focus

explore

focus

How one medical school became remarkably diverse

Lung cancer is America's deadliest cancer. Yet so few get screened

Anesthesiologist group: stop taking Ozempic before surgery

Lung cancer is America's deadliest cancer. Yet so few get screened

Moonlake's readout produced a cash windfall. Risks remain

The pain doctors face in trying to build their families

Malaria cases in Florida and Texas: Here’s what you need to know

Medical school prerequisites are outdated

Sports medicine is finally prioritizing gender equality

Liz Cheney makes 1st public comment since Trump's election interference indictments

explore

NIH chief: government has fallen behind pharma on clinical trials

An interview with Robert F. Kennedy Jr. on vaccines

After decades in use, heart stents finally beat placebo

Lung cancer is America's deadliest cancer. Yet so few get screened

Publishing genetic code of viruses could cause disaster

Baltimore teen accused of firing into crowd during block party mass shooting

explore

focus

explore

Wikipedia